SEARCH RESULTS FOR:
Jan Kengelbach
CEO, AENOVA GROUP
"Experienced CDMOs can provide companies with access to new formulation and technology methods that improve the bioavailability of difficult-to-formulate compounds."
Donna LaVoie
PRESIDENT AND CEO, LAVOIEHEALTHSCIENCE
"Companies should be ready to address hostile short-selling and unsolicited takeover bids, develop rapid responses to special meetings and activist demands, and vigorously engage with institutional shareholders, proxy advisory firms, and potential regulators."
Daniel Prince
CEO, PRINCE STERILIZATION SERVICES
"The expansion will allow Prince to more than double its headcount, increase manufacturing capacity, and offer additional ready-to-use products and sterilization services to the market."
Tom Larsen & Bill Pearson
CEO (TL) & EXECUTIVE VICE PRESIDENT OF EXPLORATION (BP), ELORO RESOURCES
"We have a remarkable opportunity at our Iska Iska asset in Bolivia to outline two world-class deposits."
Emily Thorn Corthay
FOUNDER AND CEO, THORN ASSOCIATES
"Today, most major and mid-tier mining companies have targets, and are working a plan to move it forward, but the targets are still not ambitious enough, and the industry needs to accelerate and do more, faster."
Eduardo Cossio Chirinos
CEO, INCIMMET
"Nuestro avance tecnológico más maduro es un dron equipado con una cámara técnica y un sofisticado algoritmo impulsado por inteligencia artificial. Gracias a nuestro progreso, podemos prever el desprendimiento de rocas, que representa la causa principal de accidentes fatales en minería subterránea."
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
Aloke Lohia
FOUNDER AND GROUP CEO, INDORAMA VENTURES PUBLIC COMPANY LIMITED (IVL)
"Despite being the largest PET producer globally, Indorama Ventures only captures about 1% of a very fragmented market, which is worth about US$2 trillion. There is plenty of room for growth."
Mario Theurl
MANAGING DIRECTOR – STRABAG AND ZÜBLIN
"We can contribute to the green future of Chile while simultaneously providing cleaner energy to the mining industry; this is aligned with both our sustainability goals and market demand."
Jonathan Price
CEO, TECK
"Teck is well positioned to help meet the growing demand for copper with an unrivalled suite of growth projects that could add more than 1.5 million t/y to our current copper equivalent production."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
